B. Riley analyst Mayank Mamtani lowered the firm’s price target on Agenus (AGEN) to $8 from $11 and keeps a Buy rating on the shares. The firm updated the company’s post last month’s earnings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGEN:
- Agenus: Hold Rating Amid Strategic Shifts and Valuation Risks
- Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus
- Agenus price target lowered to $3 from $6 at Baird
- Agenus’ Strategic Cost Reductions and CRC Focus Lead to Hold Rating
- Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress